Lymphoplasmacytic Lymphoma Active Not Recruiting Phase 2 Trials for Ixazomib (DB09570)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031072 (Lymphoplasmacytic Lymphoma) | Active Not Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02339922 | Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma | Treatment |